An intricate rewiring of cancer metabolism via alternative splicing

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• Alternative splicing generates protein diversity but its aberrant regulation is implicated in various diseases, including cancer.
• Metabolic and immune dysfunctions are key hallmarks of cancer, often influenced by splicing alterations.
• Alternative splicing impacts tumor initiation, proliferation, and drug resistance by modifying protein function and drug affinity.

Purpose of the Study:

• To elucidate the role of alternative splicing factors in cancer metabolism and proliferation.
• To explore the therapeutic potential of targeting aberrant alternative splicing in tumors.
• To review emerging therapeutics and associated clinical challenges for alternative splicing-targeted cancer treatments.

Main Methods:

• Review of scientific literature on alternative splicing, cancer metabolism, and therapeutics.
• Analysis of the mechanisms by which alternative splicing factors regulate cancer cell reprogramming.
• Discussion of clinical applications and challenges of targeting alternative splicing in oncology.

Main Results:

• Alternative splicing factors significantly regulate cancer cell metabolism and contribute to tumor initiation and proliferation.
• Dysregulated alternative splicing promotes carcinogenesis and confers drug resistance by altering protein targets.
• Targeting alternative splicing presents a novel therapeutic avenue for cancer treatment.

Conclusions:

• Aberrant alternative splicing is a critical driver of cancer development and progression.
• Modulating alternative splicing offers a promising strategy for novel cancer therapies.
• Further research and clinical development are needed to overcome challenges in applying these therapeutics.